Li Jing, Hou Pan, Sun Lili, Yin Shihua, Deng Zhongzi, Qi Yuan, Wang Ji
Sport Health Technology College, Jilin Sport University, Changchun, China.
College of Food Science, Jiangnan University, Wuxi, China.
J Sci Food Agric. 2025 Sep;105(12):6454-6468. doi: 10.1002/jsfa.14360. Epub 2025 May 9.
This study aimed to investigate the anti-obesity mechanism of walnut-derived peptides (WMP) combined with intermittent fasting (IF) through modulating the gut microbiota-liver metabolism axis in high-fat-diet (HFD)-induced obese mice, providing theoretical support for dietary intervention strategies.
Fifty C57BL/6 mice were divided into five groups (n = 10): normal diet, HFD, WMP, IF and WMP + IF, with an 8-week intervention. Biochemical analysis, 16S rRNA sequencing, and untargeted liver metabolomics were employed to explore the underlying mechanisms.
WMP + IF significantly alleviated hyperlipidemia, glucose metabolism disorders, insulin resistance, and visceral fat deposition in HFD mice, while suppressing systemic inflammation. Gut microbiota analysis revealed reduced abundance of Firmicutes, Kineothrix, and Dubosiella, along with a decreased Firmicutes/Bacteroidota (F/B) ratio, whereas Bacteroidota and CAG-873 were enriched. Correlation analysis demonstrated positive associations between Firmicutes and obesity-related markers (lipid profiles, liver dysfunction, pro-inflammatory cytokines), while Bacteroidota exhibited negative correlations. Untargeted metabolomics identified upregulated levels of 16-hydroxypalmitic acid and 13-S-hydroxyoctadecadienoic acid (13(S)-HODE), alongside activation of ABC transporters and galactose metabolism pathways. Notably, 13(S)-HODE showed negative correlations with Firmicutes, F/B ratio, and Kineothrix, but positive correlations with Bacteroidota and CAG-873.
The synergistic anti-obesity effects of WMP and IF are mediated through restoring gut microbial balance and reprogramming hepatic metabolic pathways. These findings highlight novel mechanisms involving the gut-liver axis, offering innovative strategies for obesity prevention through natural bioactive compounds combined with dietary interventions. © 2025 Society of Chemical Industry.
本研究旨在通过调节高脂饮食(HFD)诱导的肥胖小鼠的肠道微生物群-肝脏代谢轴,探讨核桃衍生肽(WMP)联合间歇性禁食(IF)的抗肥胖机制,为饮食干预策略提供理论支持。
将50只C57BL/6小鼠分为五组(n = 10):正常饮食组、HFD组、WMP组、IF组和WMP + IF组,进行为期8周的干预。采用生化分析、16S rRNA测序和非靶向肝脏代谢组学来探索潜在机制。
WMP + IF显著减轻了HFD小鼠的高脂血症、糖代谢紊乱、胰岛素抵抗和内脏脂肪沉积,同时抑制了全身炎症。肠道微生物群分析显示,厚壁菌门、动丝菌属和杜波氏菌属的丰度降低,厚壁菌门/拟杆菌门(F/B)比值下降,而拟杆菌门和CAG-873富集。相关性分析表明,厚壁菌门与肥胖相关标志物(血脂谱、肝功能障碍、促炎细胞因子)呈正相关,而拟杆菌门呈负相关。非靶向代谢组学鉴定出16-羟基棕榈酸和13-S-羟基十八碳二烯酸(13(S)-HODE)水平上调,同时ABC转运蛋白和半乳糖代谢途径被激活。值得注意的是,13(S)-HODE与厚壁菌门、F/B比值和动丝菌属呈负相关,但与拟杆菌门和CAG-873呈正相关。
WMP和IF的协同抗肥胖作用是通过恢复肠道微生物平衡和重新编程肝脏代谢途径来介导的。这些发现突出了涉及肠-肝轴的新机制,为通过天然生物活性化合物与饮食干预相结合预防肥胖提供了创新策略。© 2025化学工业协会。